Skip to content

Intranasal Diagnostics in Food Allergy: a Feasibility Study

Phase 1/2 Study to Determine the Intranasal Allergen Threshold to Food Proteins in Children With Food Allergy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02159833
Acronym
INDY
Enrollment
31
Registered
2014-06-10
Start date
2014-10-31
Completion date
2019-01-04
Last updated
2024-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food Allergy

Keywords

Food allergy, Diagnosis

Brief summary

The investigators will conduct low-dose intranasal allergen challenges on children/adolescents with a diagnosis of food allergy to egg/cow's milk/soya/wheat/peanut. The data will be used to determine the safety and potential utility of intranasal food challenges in the diagnosis of food allergy.

Interventions

OTHERIntranasal challenge with active substance (food protein)
OTHERIntranasal challenge with placebo

Sponsors

National Institute for Health Research, United Kingdom
CollaboratorOTHER_GOV
Imperial College London
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Aged 6 - 17 years old * Physician-diagnosis of food allergy on the basis of: * Positive oral food challenge to the causative food (conducted under medical supervision) within the last 12 months; OR * History of convincing clinical reaction to the causative food within the last 12 months AND positive skin prick test within last 12 months; OR * Evidence of \>95% likelihood of food allergy (on the basis of serum specific IgE or skin prick test (SPT) 8mm or above to the causative food allergen within past 12 months * Written informed consent from parent/guardian, with assent from children aged 8 years and above wherever possible. Participants aged over 16 years will need to provide their owned informed consent.

Exclusion criteria

* Contraindicated as acutely unwell or current unstable asthma: * Acute wheeze in last 72 hours requiring treatment * Febrile ≥38.0oC in last 72 hours * Recent admission to hospital in last 2 weeks for acute asthma * Current medication * Use of asthma reliever medication in last 72 hours * Recent administration of a medication containing antihistamine within the last 4 days * Current oral steroid for asthma exacerbation or course completed within last 2 weeks

Design outcomes

Primary

MeasureTime frameDescription
Physiological response to intranasal challenge with a food protein20minsThe physiological response to food (egg/cow's milk/soya/wheat/peanut) protein when administered into the human nasal airway in food-allergic children with the corresponding food allergy. This will be assessed objectively (using acoustic rhinometry and peak nasal inspiratory flow) as well as subjectively (using a validated Symptom Scoring questionnaire).

Secondary

MeasureTime frameDescription
Intranasal threshold to food protein20 minsThe intranasal threshold to food (egg/cow's milk/soya/wheat/peanut) protein to elicit a local physiological response in food-allergic children (with the corresponding food allergy), as defined by objective assessment described above.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026